BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 22592047)

  • 1. Role of positron emission tomography-computed tomography in the management of anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography/computed tomography in the staging and treatment of anal cancer.
    Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
    De Nardi P; Guarneri G; Canevari C; Tamburini A; Slim N; Passoni P; Rosati R
    Colorectal Dis; 2019 Sep; 21(9):1017-1024. PubMed ID: 31077550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.
    Jakobsen JK; Alslev L; Ipsen P; Costa JC; Krarup KP; Sommer P; Nerstrøm H; Toft BG; Høyer S; Bouchelouche K; Jensen JB
    BJU Int; 2016 Jul; 118(1):102-11. PubMed ID: 26216234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy in squamous-cell carcinoma of the anal canal.
    De Nardi P; Carvello M; Canevari C; Passoni P; Staudacher C
    Ann Surg Oncol; 2011 Feb; 18(2):365-70. PubMed ID: 20803079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
    Rosevear HM; Williams H; Collins M; Lightfoot AJ; Coleman T; Brown JA
    Urol Oncol; 2012 Sep; 30(5):723-6. PubMed ID: 21396850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Ono CR; Lynn P; Bailão Aguilar P; Nahas SC; Gama-Rodrigues J; Buchpiguel CA
    Colorectal Dis; 2013 Jun; 15(6):674-82. PubMed ID: 23374979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
    Jones M; Hruby G; Solomon M; Rutherford N; Martin J
    Ann Surg Oncol; 2015 Oct; 22(11):3574-81. PubMed ID: 25652048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
    Blom RL; Vliegen RF; Schreurs WM; Belgers HJ; Stohr I; Oostenbrug LE; Sosef MN
    Dis Esophagus; 2012 Aug; 25(6):555-9. PubMed ID: 22150869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
    Mohammadkhani Shali S; Schmitt V; Behrendt FF; Winz OH; Heinzel A; Mottaghy FM; Eble MJ; Verburg FA
    Eur J Radiol; 2016 Aug; 85(8):1390-4. PubMed ID: 27423677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study.
    Schlenker B; Scher B; Tiling R; Siegert S; Hungerhuber E; Gratzke C; Tilki D; Reich O; Schneede P; Bartenstein P; Stief CG; Seitz M
    Urol Oncol; 2012; 30(1):55-9. PubMed ID: 20022269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT in anal cancer - is it worth doing?
    Wells IT; Fox BM
    Clin Radiol; 2012 Jun; 67(6):535-40. PubMed ID: 22208962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
    Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
    Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients.
    Slim N; Passoni P; Incerti E; Tummineri R; Gumina C; Cattaneo GM; De Nardi P; Canevari C; Fiorino C; Ronzoni M; Tamburini AM; Burgio V; Gianolli L; Di Muzio N
    Sci Rep; 2020 Sep; 10(1):14613. PubMed ID: 32884036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.